SHE:002581 Revenue

Shandong Sinobioway Biomedicine had revenue of 141.28M CNY in the quarter ending September 30, 2025, with 35.94% growth. This brings the company's revenue in the last twelve months to 257.74M, down -36.54% year-over-year. In the year 2024, Shandong Sinobioway Biomedicine had annual revenue of 360.41M, down -16.14%.

Revenue (ttm)

257.74M

Revenue Growth

-36.54%

P/S Ratio

21.30

Revenue / Employee

541.48K

Employees

476

Market Cap

5.49B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	360.41M	-69.39M	-16.14%
Dec 31, 2023	429.79M	72.71M	20.36%
Jan 1, 2023	357.08M	-45.63M	-11.33%
Jan 1, 2022	402.71M	125.88M	45.47%
Dec 31, 2020	276.83M	-290.81M	-51.23%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
ZhuZhou QianJin Pharmaceutical Co.,Ltd	3.63B
Beijing Science Sun Pharmaceutical	402.23M
Zhuhai Rundu Pharmaceutical	1.19B
Teyi Pharmaceutical Group Co.,Ltd	924.04M
Hunan Fangsheng Pharmaceutical	1.68B
Zhejiang Sunflower Great Health	302.92M
Luoxin Pharmaceuticals Group Stock	2.49B
Hubei Biocause Heilen Pharmaceutical	430.77M

Revenue Rankings